Use of Fluorescence in situ Hybridization to Predict Patient Response to BCG Therapy for Bladder Cancer: Results of a Prospective Trial

PURPOSE: No reliable methods currently exist to predict patient response to intravesical immunotherapy with bacillus Calmette-Guérin (BCG), given after transurethral resection for high-risk non-muscle-invasive bladder cancer. We initiated a prospective clinical trial to determine whether fluorescenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kamat, Ashish M., Dickstein, Rian J., Messetti, Fabrizio, Anderson, Roosevelt, Pretzsch, Shanna M., Gonzalez, Graciela Noguera, Katz, Ruth L., Khanna, Abha, Zaidi, Tanweer, Wu, Xifeng, Grossman, H. Barton, Dinney, Colin P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278506/
https://ncbi.nlm.nih.gov/pubmed/22245325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2011.10.144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados